NCT05501353View on ClinicalTrials.gov

Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods

RecruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

July 22, 2022

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
Colorectal Cancer Metastatic
Interventions
OTHER

no intervention

This study is an observational study, which does not affect the routine diagnosis and treatment of patients and only requires the collection of biological samples at specific nodes

Trial Locations (1)

310000

RECRUITING

the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
collaborator

Guangzhou Burning Rock Dx Co., Ltd.

INDUSTRY

collaborator

Guangdong Living Environment Harmless Treatment Center Co., Ltd.

UNKNOWN

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER